dezocine FDA Link

potent analgesic; RN given refers to ((5R-(5alpha,11alpha,13S*)))-isomer (dezocin); structure

Also Known As:

(-5alpha, 11alpha,13s)- 13- amino- 5,6,7,8,9,10,11,12- octahydro- 5- methyl- 5,11- methanobenzocyclodecen- 3- ol; 13- amino- 5,6,7,8,9,10,11,12- octahydro- 5- methyl- 5,11- methanobenzocyclodecenol; 5,11-methanobenzocyclodecen-3-ol, 13- amino- 5,6,7,8,9,10,11,12- octahydro- 5- methyl- , (5alpha,11alpha,13s*); Wy-16,225; dezocine hydrobromide, (5R-(5alpha,11alpha,13S*))-isomer; dezocine hydrobromide, (5S-(5alpha,11alpha,13*))-isomer; dezocine hydrobromide, (5alpha,11alpha,13*)-isomer; dezocine hydrobromide, (5alpha,11alpha,13S*)-isomer; dezocine, (5alpha,11alpha,13S*)-isomer; 5,11-Methanobenzocyclodecen-3-ol, 5,6,7,8,9,10,11,12- octahydro- 13- amino- 5- methyl-

Pharmalogical Action Categories:

D000701 - Analgesics, Opioid

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        dezocine: 137
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - dezocine: 137
Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - dezocine: 137

Zhifeng Lv Selected Research

Zhifeng Lv Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure